Copyright
©The Author(s) 2024.
World J Gastroenterol. Dec 28, 2024; 30(48): 5162-5173
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5162
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5162
Figure 2 Flow-chart of study population enrollment.
Excessive pharyngeal acid reflux (PAR) is defined as PAR ≥ 2 episodes; Excessive distal esophageal acid reflux (EAR) a is defined as distal EAR total time ≥ 4.2% of 24-hour, or ≥ 6.3% of upright position, or ≥ 1.2% of supine position; Composite pH (+) is defined as PAR (+) and/or EAR (+); Both pH (+) is denoted as PAR (+) and EAR (+); Both pH (-) is denoted as non-reflux controls. PPI: Proton pump inhibitor.
- Citation: Chen YY, Wang CC, Chuang CY, Tsou YA, Peng YC, Chang CS, Lien HC. Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy. World J Gastroenterol 2024; 30(48): 5162-5173
- URL: https://www.wjgnet.com/1007-9327/full/v30/i48/5162.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i48.5162